FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)

View source ↗

Summary

The FDA approved Pfizer's supplemental application for Revatio (sildenafil citrate), indicating FDA approval of the requested changes to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)